BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23053648)

  • 1. Targeting the HOX/PBX dimer in breast cancer.
    Morgan R; Boxall A; Harrington KJ; Simpson GR; Gillett C; Michael A; Pandha HS
    Breast Cancer Res Treat; 2012 Nov; 136(2):389-98. PubMed ID: 23053648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting HOX and PBX transcription factors in ovarian cancer.
    Morgan R; Plowright L; Harrington KJ; Michael A; Pandha HS
    BMC Cancer; 2010 Mar; 10():89. PubMed ID: 20219106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer).
    Plowright L; Harrington KJ; Pandha HS; Morgan R
    Br J Cancer; 2009 Feb; 100(3):470-5. PubMed ID: 19156136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXA9 versus HOXB9; particular focus on their controversial role in tumor pathogenesis.
    Hjazi A; Jasim SA; Al-Dhalimy AMB; Bansal P; Kaur H; Qasim MT; Mohammed IH; Deorari M; Jawad MA; Zwamel AH
    J Appl Genet; 2024 May; ():. PubMed ID: 38753266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide-based inhibition of the HOXA9/PBX interaction retards the growth of human meningioma.
    Ando H; Natsume A; Senga T; Watanabe R; Ito I; Ohno M; Iwami K; Ohka F; Motomura K; Kinjo S; Ito M; Saito K; Morgan R; Wakabayashi T
    Cancer Chemother Pharmacol; 2014 Jan; 73(1):53-60. PubMed ID: 24141373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOX transcription factors are potential targets and markers in malignant mesothelioma.
    Morgan R; Simpson G; Gray S; Gillett C; Tabi Z; Spicer J; Harrington KJ; Pandha HS
    BMC Cancer; 2016 Feb; 16():85. PubMed ID: 26867567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of HOX gene expression patterns in human breast cancer.
    Hur H; Lee JY; Yun HJ; Park BW; Kim MH
    Mol Biotechnol; 2014 Jan; 56(1):64-71. PubMed ID: 23820980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting HOX transcription factors in prostate cancer.
    Morgan R; Boxall A; Harrington KJ; Simpson GR; Michael A; Pandha HS
    BMC Urol; 2014 Feb; 14():17. PubMed ID: 24499138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of specific HOX gene expression patterns in ovarian cancer.
    Kelly Z; Moller-Levet C; McGrath S; Butler-Manuel S; Kavitha Madhuri T; Kierzek AM; Pandha H; Morgan R; Michael A
    Int J Cancer; 2016 Oct; 139(7):1608-17. PubMed ID: 27225067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOX genes and their role in the development of human cancers.
    Bhatlekar S; Fields JZ; Boman BM
    J Mol Med (Berl); 2014 Aug; 92(8):811-23. PubMed ID: 24996520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting HOX/PBX dimers in cancer.
    Morgan R; El-Tanani M; Hunter KD; Harrington KJ; Pandha HS
    Oncotarget; 2017 May; 8(19):32322-32331. PubMed ID: 28423659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PBX3 is an important cofactor of HOXA9 in leukemogenesis.
    Li Z; Zhang Z; Li Y; Arnovitz S; Chen P; Huang H; Jiang X; Hong GM; Kunjamma RB; Ren H; He C; Wang CZ; Elkahloun AG; Valk PJ; Döhner K; Neilly MB; Bullinger L; Delwel R; Löwenberg B; Liu PP; Morgan R; Rowley JD; Yuan CS; Chen J
    Blood; 2013 Feb; 121(8):1422-31. PubMed ID: 23264595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOXC6: A promising biomarker linked to an immunoevasive microenvironment in colorectal cancer based on TCGA analysis and cohort validation.
    Weng M; Lai Y; Ge X; Gu W; Zhang X; Li L; Sun M
    Heliyon; 2024 Jan; 10(1):e23500. PubMed ID: 38192826
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential.
    Tang L; Peng L; Tan C; Liu H; Chen P; Wang H
    Cancer Cell Int; 2022 Nov; 22(1):349. PubMed ID: 36376832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonic Programs in Cancer and Metastasis-Insights From the Mammary Gland.
    Lee MY
    Front Cell Dev Biol; 2022; 10():938625. PubMed ID: 35846378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer.
    Morgan R; Hunter K; Pandha HS
    Int J Cancer; 2022 Jun; 150(12):1919-1932. PubMed ID: 35080776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeobox Genes in Cancers: From Carcinogenesis to Recent Therapeutic Intervention.
    Feng Y; Zhang T; Wang Y; Xie M; Ji X; Luo X; Huang W; Xia L
    Front Oncol; 2021; 11():770428. PubMed ID: 34722321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MEIS1 in Hematopoiesis and Cancer. How MEIS1-PBX Interaction Can Be Used in Therapy.
    Blasi F; Bruckmann C
    J Dev Biol; 2021 Oct; 9(4):. PubMed ID: 34698191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBX1-directed stem cell transcriptional program drives tumor progression in myeloproliferative neoplasm.
    Muggeo S; Crisafulli L; Uva P; Fontana E; Ubezio M; Morenghi E; Colombo FS; Rigoni R; Peano C; Vezzoni P; Della Porta MG; Villa A; Ficara F
    Stem Cell Reports; 2021 Nov; 16(11):2607-2616. PubMed ID: 34678207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular features and vulnerabilities of recurrent chordomas.
    Seeling C; Lechel A; Svinarenko M; Möller P; Barth TFE; Mellert K
    J Exp Clin Cancer Res; 2021 Jul; 40(1):244. PubMed ID: 34330313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.